MICRON TECHNOLOGY INC Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Micron Technology Inc quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q3 2010 to Q3 2024.
  • Micron Technology Inc Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending August 29, 2024 was $5.42B, a 165% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.42B +$3.37B +165% Aug 29, 2024 10-K 2024-10-04
Q2 2024 $4.42B +$2.37B +116% May 30, 2024 10-Q 2024-06-27
Q1 2024 $3.65B +$1.76B +92.9% Feb 29, 2024 10-Q 2024-03-21
Q4 2023 $2.48B -$397M -13.8% Nov 30, 2023 10-Q 2023-12-21
Q3 2023 $2.05B -$2.72B -57% Aug 31, 2023 10-K 2024-10-04
Q2 2023 $2.04B -$3.85B -65.4% Jun 1, 2023 10-Q 2023-06-29
Q1 2023 $1.89B -$3.17B -62.6% Mar 2, 2023 10-Q 2023-03-29
Q4 2022 $2.88B -$2.05B -41.6% Dec 1, 2022 10-Q 2022-12-22
Q3 2022 $4.77B -$155M -3.15% Sep 1, 2022 10-K 2023-10-06
Q2 2022 $5.9B +$2.07B +54.1% Jun 2, 2022 10-Q 2022-07-01
Q1 2022 $5.06B +$2.05B +68.3% Mar 3, 2022 10-Q 2022-03-30
Q4 2021 $4.92B +$1.74B +54.7% Dec 2, 2021 10-Q 2022-01-06
Q3 2021 $4.92B +$1.43B +40.8% Sep 2, 2021 10-K 2022-10-07
Q2 2021 $3.83B +$562M +17.2% Jun 3, 2021 10-Q 2021-07-01
Q1 2021 $3.01B +$312M +11.6% Mar 4, 2021 10-Q 2021-04-01
Q4 2020 $3.18B +$152M +5.02% Dec 3, 2020 10-Q 2021-01-08
Q3 2020 $3.49B +$716M +25.8% Sep 3, 2020 10-K 2021-10-08
Q2 2020 $3.27B +$417M +14.6% May 28, 2020 10-Q 2020-06-30
Q1 2020 $2.7B -$1.3B -32.6% Feb 27, 2020 10-Q 2020-03-26
Q4 2019 $3.03B -$1.95B -39.2% Nov 28, 2019 10-Q 2019-12-20
Q3 2019 $2.78B -$2.28B -45.1% Aug 29, 2019 10-K 2020-10-19
Q2 2019 $2.85B -$1.67B -36.9% May 30, 2019 10-Q 2019-06-26
Q1 2019 $4B -$53M -1.31% Feb 28, 2019 10-Q 2019-03-21
Q4 2018 $4.98B +$1.38B +38.2% Nov 29, 2018 10-Q 2018-12-19
Q3 2018 $5.06B +$1.57B +44.9% Aug 30, 2018 10-K 2019-10-17
Q2 2018 $4.51B +$1.33B +41.6% May 31, 2018 10-Q 2018-06-22
Q1 2018 $4.05B +$1.52B +60.2% Mar 1, 2018 10-Q 2018-03-23
Q4 2017 $3.6B +$1.44B +66.7% Nov 30, 2017 10-Q 2017-12-20
Q3 2017 $3.49B +$1.73B +97.7% Aug 31, 2017 10-K 2018-10-15
Q2 2017 $3.19B +$1.44B +82% Jun 1, 2017 10-Q 2017-06-30
Q1 2017 $2.53B +$834M +49.2% Mar 2, 2017 10-Q 2017-03-28
Q4 2016 $2.16B +$223M +11.5% Dec 1, 2016 10-Q 2017-01-09
Q3 2016 $1.77B -$423M -19.3% Sep 1, 2016 10-K 2017-10-26
Q2 2016 $1.75B -$509M -22.5% Jun 2, 2016 10-Q 2016-07-06
Q1 2016 $1.69B -$745M -30.5% Mar 3, 2016 10-Q 2016-04-08
Q4 2015 $1.94B -$362M -15.7% Dec 3, 2015 10-Q 2016-01-08
Q3 2015 $2.19B -$336M -13.3% Sep 3, 2015 8-K 2017-10-10
Q2 2015 $2.26B -$96M -4.07% Jun 4, 2015 10-Q 2015-07-10
Q1 2015 $2.44B -$109M -4.28% Mar 5, 2015 10-Q 2015-04-10
Q4 2014 $2.3B -$232M -9.16% Dec 4, 2014 10-Q 2015-01-09
Q3 2014 $2.52B +$455M +22% Aug 28, 2014 10-K 2015-10-27
Q2 2014 $2.36B +$1.11B +88.6% May 29, 2014 10-Q 2014-07-03
Q1 2014 $2.55B +$1.55B +155% Feb 27, 2014 10-Q 2014-04-07
Q4 2013 $2.53B +$1.67B +194% Nov 28, 2013 10-Q 2014-01-07
Q3 2013 $2.07B +$1.14B +122% Aug 29, 2013 10-K 2014-10-27
Q2 2013 $1.25B +$277M +28.5% May 30, 2013 10-Q 2013-07-08
Q1 2013 $998M +$85M +9.31% Feb 28, 2013 10-Q 2013-04-08
Q4 2012 $863M -$183M -17.5% Nov 29, 2012 10-Q 2013-01-07
Q3 2012 $933M -$172M -15.6% Aug 30, 2012 8-K 2014-07-22
Q2 2012 $973M -$92M -8.64% May 31, 2012 10-Q 2012-07-09
Q1 2012 $913M -$148M -13.9% Mar 1, 2012 10-Q 2012-04-09
Q4 2011 $1.05B -$40M -3.68% Dec 1, 2011 10-Q 2012-01-10
Q3 2011 $1.11B -$133M -10.7% Sep 1, 2011 10-K 2012-10-29
Q2 2011 $1.07B Jun 2, 2011 10-Q 2011-07-12
Q1 2011 $1.06B Mar 3, 2011 10-Q 2011-04-12
Q4 2010 $1.09B Dec 2, 2010 10-Q 2011-01-11
Q3 2010 $1.24B Sep 2, 2010 10-K 2011-10-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.